PCSK1N and synucleinopathy: Alpha-synuclein seed amplification assays (αSyn-SAAs) are a class of ultrasensitive diagnostic assays with the capacity to effectively distinguish Parkinson’s disease (PD) patients from healthy controls and to differentiate PD from other related synucleinopathies.